PIN80 Traditional Medicine use and its impact on antiretroviral Therapy Adherence Among Hiv Patients In Ethiopia  by Legesse, B. & Shewamene, Z.
 VA L U E  I N  H E A LT H  1 8  ( 2 0 1 5 )  A 1 – A 3 0 7  A241
cope with forgetfulness, specifically employing strategies to overcome busyness 
in schedules, being away from home and tiredness.
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OBJECTIVES: The study aimed to assess the pattern of traditional medicine(TM) 
use and its impact on antiretroviral therapy (ART) adherence among HIV patients 
in Addis Ababa, Ethiopia. METHODS: A cross-sectional study was conducted 
among HIV patients on ART in Addis Ababa public ART clinics, from September 
to October 2013. The study population consisted of 845 HIV patients who were on 
ART at least for six months, selected by systematic sampling technique from nine 
randomly selected clinics. Data were collected by trained health professionals 
through face-to-face interview of patients, using pre-tested questionnaire. Data 
were entered to Epi-info version 7 and analyzed by SPSS version 16. Logistic regres-
sion was used to assess the impact of TM use on ART adherence. RESULTS: Eight 
hundred forty-five patients were included in the study, 572 (67.7%) of which were 
females. A third (33.2%) of the patients were TM and ART concomitant users. Most 
frequently used TM were Alium sativum (34%) and Ocimum lamifolia (28%); mainly 
for the purpose of managing HIV/AIDS related symptoms (61.2%). Most (68.7%) 
of the patients were using TM without consulting health professionals. Factors 
independently associated with concomitant TM and ART use were perceived qual-
ity of service in ART clinics (poor vs good, AOR 2.35; 95% CI 1.78-3.44), number of 
ART side effects reported (≥ 3 vs ≤ 1, AOR 2.61 95%CI 1.53-5.47) and self-perceived 
health status (poor vs good, AOR 2.14; 95% CI 1.62-6.31). Concomitant TM and ART 
use had statistically significant association with poor ART adherence (AOR 3.15; 
95% CI 2.32-6.32). CONCLUSIONS: The study revealed that many patients used TM 
concomitant to ART. Since TM use among the patients was found to impact their 
ART adherence and because of the possibility for interaction, patients should be 
advised to consult their health care providers when they need to take TM while 
on ART.
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OBJECTIVES: The outbreak of Ebola in 2014 has been the largest in history, affecting 
multiple countries in West Africa and cases were diagnosed within the United States 
as well. This study uses the framework of the Health Belief Model and aims to under-
stand the perceptions of a cohort of individuals in Houston, Texas towards this out-
break, measured as the likelihood of performing preventive behaviors. METHODS: 
This is a prospective, cross sectional study design with an anonymous, self-admin-
istered survey based on the constructs of the Health Belief Model. Individuals aged 
18 or older were requested for their participation by convenience sampling at public 
places in Houston, Texas between 4th November and 28th December 2014. The 
variables measured were perceived susceptibility, perceived severity, perceived 
threat, knowledge about Ebola, self-efficacy and existing health belief. For statisti-
cal analysis the Health Belief Model based statements in the survey were grouped 
as per domain, the scores were summed up to give the variable values, which were 
tested in a multiple regression model. RESULTS: A total of 283 participants aged 
18 to 74 (Mean: 34.5±12.7, 54.8% male) completed the survey. Of the Health Belief 
Model constructs tested for, perceived susceptibility (p= 0.0366), perceived threat 
(p< 0.0001), educational level (p= 0.0470), actively following the news (p= 0.0015) 
and existing health belief (p= 0.0003) were predictors of the likelihood to perform 
preventive health behaviors. CONCLUSIONS: The Health Belief Model adequately 
predicted public perception regarding their belief about the threat of the disease 
and susceptibility towards the disease. Educating the public about the actual risks 
of Ebola in United States through various media can elicit appropriate behavior in 
any future cases of outbreak within the United States.
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OBJECTIVES: We sought to identify pneumonia knowledge among participants in the 
Pharmacist’s Pneumonia Prevention Project (PPPP), a community-based education 
and vaccination program administered to older Philadelphians in 2014. METHODS: 
Participants were aged 50+, cognitively intact, English speaking and recruited from 
senior centers and churches with a predominantly black population in Philadelphia. 
This analysis reports baseline data which were collected prior to delivery of PPPP. 
Knowledge and awareness of pneumonia was assessed with a 22-item question-
naire encompassing the following domains: susceptibility to infection, symptoms 
of disease, severity of illness, and vaccination with an emphasis on vaccine efficacy, 
safety, and eligibility. RESULTS: 203 individuals were enrolled, of whom 75% were 
female and 80% were black, with a mean age of 74(SD 9) years. Additionally, 148 
(73%) participants had at least a high school education. Of the 203 participants, 97 
(48%) described pneumonia in their own words, but only 33 of these (34%) correctly 
described it as an infection in the lungs. When asked about the best way to prevent 
pneumonia, 47% of participants reported answers other than vaccination. Compared 
to women, more men were unaware of the individuals who were at risk of getting 
pneumonia. Specifically, 81% of men did not think that the very young were at risk of 
getting the disease (vs. 56% of women; p= 0.032). Additionally, 76% of men were una-
ware that patients with a low immune system were at risk for pneumonia (vs. 39% of 
women; p= 0.002). CONCLUSIONS: Findings revealed critical knowledge gaps about 
pneumonia, underscoring the need for educational approaches which resonate with 
this study is to determine the cost-effectiveness of a PCV13 vaccination program 
versus a PPSV23 program in high risk adults 18 years old and over with a coverage 
of 100% and in healthy adults 65 years old with a coverage of 90%, in the Chilean 
Health System. METHODS: A cost/utility study was performed using a Markov 
model (population data for a time horizon of 10 years). Utilities and epidemio-
logical data like incidence, mortality, and consequences of pneumococcal disease 
were obtained from Chilean, Latin American and International published literature. 
Vaccine’s efficacies were taken from literature for PPSV23 and from the Community-
Acquired Pneumonia Immunization Trial in Adults (CAPITA) for PCV13. Direct and 
indirect costs were considered and were obtained from FONASA, the Chilean Public 
Health Insurance. Vaccine’s costs and quality-adjusted life of years (QALYs) were 
determined and compared. RESULTS: With a PCV13 vaccination program, 107 cases 
of bacteremia, 13 of meningitis, 6,706 of inpatient pneumonia, 4,509 of outpatient 
pneumonia and 1,189 deaths were avoided compared with PPSV23 program. The 
total cost over the 10 year period studied, and for the total population of 12,773,697 
people, was $1,994,404 for PCV13 and $2,026,510 for PPSV23. For PCV13, QALYs 
were 11,484,554 and for PPSV23, QALYs were 11,479,124, thus the Incremental Cost/
Effectiveness Ratio (ICER) was dominant for PCV13, and these results do not vary 
with sensitivity analysis on high impact variables. CONCLUSIONS: A PCV13 vac-
cination program is dominant over a PPSV23 program, and a population program 
with PCV13 would save public health expenses and reduce morbidity, mortality 
and disability in Chilean adults over 18 years old. These results appear to be robust 
under a variety of sensitivity analysis.
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OBJECTIVES: Human immunodeficiency virus (HIV) treatment guidelines recom-
mend target adherence levels of 95% and suggest that treatment be postponed in 
patients at risk of poor adherence. Little objective guidance is provided to clini-
cians for identifying such patients. We applied an optimal data analysis (ODA) 
paradigm to create predictive models for adherence in a national cohort of United 
States veterans using electronic medical records (EMRs) by maximizing predic-
tive accuracy. METHODS: Quarterly adherence to antiretroviral agents was calcu-
lated as the proportion of days covered (PDC) with 3 or more antiretroviral agents 
from 2 or more drug classes. A hierarchical decision tree was built to predict 
patient adherence at different adherence thresholds of 75%, 80%, 85%, 90% and 
95%. The attribute variables included demographics, comorbidities, and disease 
characteristics. Three rules were applied to pick the predictors: 1) at each deci-
sion point, the attribute with the lowest Fisher’s exact p-value was selected; 2) 
leave-one-out jackknife analysis was performed to select a stable attribute; and 
3) dividing a branch of decision tree was stopped if the branch had less than 
15 patients. RESULTS: 3864 HIV patients newly initiated highly active antiret-
roviral therapy in 1998-2006. The mean age of the cohort was 56.3±9.4 year old 
and 98.4% were males. The mean (95% CI) PDC in quarter 1 was 20.9% (41.6-45.0) 
and reached a maximum of 43.3% (20.2-21.7) in quarter 26. The ODA models for 
different thresholds predicted adherence with a C-statistic of 0.58-0.63, a range 
of accuracy defined as no discrimination to poor discrimination. Patients who 
were most non-adherent were those who were < 60 years old, black, treated with 
protease inhibitors and drug abuser. CONCLUSIONS: Using discrete data in the 
EMRs, it is difficult to predict patients at risk of poor adherence. Future work 
should include more complex predictors such as patient adherence to other 
therapies.
PIN79
The relaTIoNshIP beTweeN PaTIeNT-relaTed facTors aNd MedIcaTIoN 
adhereNce aMoNg NIgerIaN PaTIeNTs TaKINg hIghly acTIve 
aNTIreTrovIral TheraPy
Nduaguba O.1, Soremekun R.2, Olugbake O.2, Barner J.C.1
1The University of Texas at Austin, Austin, TX, USA, 2University of Lagos, Lagos, Nigeria
OBJECTIVES: The objectives of this study were to describe and compare adherence 
rates and to determine what factors are related to adherence to therapy among 
patients living with HIV/AIDS receiving Highly Active Antiretroviral Therapy 
(HAART) in a treatment center in Lagos, Nigeria. METHODS: Patients in the study 
were living with HIV/AIDS, 18 years or older, receiving HAART, and had visited 
the clinic between June and July 2012. Adherence was measured using two self-
reported measures: number of doses taken over the past two weeks/number of 
doses provided over the past two weeks and the valid and reliable Morisky scale. 
Barriers, satisfaction with therapy, and sociodemographic and clinical variables 
served as independent variables. Data were collected via self-administered sur-
veys. Descriptive statistics, Pearson’s correlation, McNemar’s test, Pearson’s chi-
square test, analysis of variance, and logistic regression were used to address study 
objectives. RESULTS: The majority of the study sample (N= 361) were between 18 
and 40 (64.9%), female (58.3%), married (64.8%), working (83.8%), and on HAART for 
at least one year (82.0%) while a plurality of the sample had a college education 
(46.5%). Most of the patients (79.5%) reported 100% adherence using two-week self-
recall and 49.6% using the Morisky scale. Both methods used to measure adher-
ence were significantly correlated (rho= 0.476; p< 0.001). The significant (p< 0.01) 
barriers to adherence between those 100% and < 100% adherent were forgetfulness, 
running out of medication, alcohol use, and medication side effects. Multivariate 
logistic regression analysis showed that for every unit increase in the number of 
barriers, patients were 60.8% less likely to be 100% adherent (p< 0.001, OR= 0.392, 
95% CI= 0.295-0.523). CONCLUSIONS: Interventions should target helping patients 
